Health Nucleus AI Visibility Market Strategy Report - DNA Testing Kits

Answer Capsule

Health Nucleus recorded zero mentions, zero valid recommendations, and zero top-three placements across 563 qualified observations in October 2026, making it the only tracked brand in the DNA Testing Kits category with no measurable AI recommendation presence. The benchmark shows the brand declined in each of the three months since the July 2026 baseline, falling from 0.8% valid recommendation coverage to 0.0%. The clearest weakness is total absence from every tracked AI platform, including ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode. The clearest opportunity is re-entry into the brand recommendation cluster, where every other tracked competitor still holds at least a marginal position.

Who This Report Is For

This report is written for Health Nucleus leadership, category strategists, and marketing decision-makers evaluating how the brand appears in AI-generated recommendations for DNA testing kits and where it stands relative to the ten-brand competitive set tracked by the LLM Authority Index.

Report Card

Executive Summary

Health Nucleus holds no measurable AI recommendation presence in the October 2026 DNA Testing Kits benchmark. Across 563 qualified observations, the brand recorded zero mentions, zero valid recommendations, zero top-three placements, and zero rank-one placements. Its raw mention presence rate is 0.00%, its valid recommendation coverage is 0.00%, and its net sentiment score is 0.0000.

This is not a case of visibility without recommendation conversion. It is a case of no visibility at all. Every other tracked brand in the category, including the smallest players such as tellmeGen and CRI Genetics, registered at least a marginal presence in the qualified observation set. Health Nucleus did not.

The benchmark shows the brand declined in each of the three months since the July 2026 baseline. In July 2026, Health Nucleus held 0.8% valid recommendation coverage and 0.8% presence. By October 2026, both figures had fallen to 0.00%, a decline the benchmark classifies as beyond normal month-to-month variation.

The strongest cluster in the benchmark, Best DNA Testing Kits - Discovery & Evaluation, produced 563 qualified observations in October 2026. Health Nucleus appeared in none of them. The two other clusters, DNA Testing Kit Comparisons and DNA Testing Kit Pricing, produced no qualified observations in the current public series, so no signal exists there either.

The strongest platform signal for the category overall is Google AI Overviews, which carried the largest share of qualified observations. Health Nucleus registered zero presence on that platform and on every other tracked surface. The clearest platform gap is therefore total: the brand is absent from ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode alike.

The benchmark identifies where attention is warranted. For Health Nucleus, the finding is unambiguous: the brand has fallen out of the AI recommendation layer entirely, and the category continues to move without it.

What Health Nucleus Is Winning

There is no evidence-backed win to report for Health Nucleus in the October 2026 benchmark.

The brand recorded zero positive mentions, zero neutral mentions, and zero negative mentions. It holds no rank-one placements, no top-three placements, and no valid recommendations. It does not appear in any of the six tracked AI platform families.

The one neutral observation is that Health Nucleus carries no negative framing in the dataset, because it carries no framing at all. That is not a win. It is an absence.

Where Health Nucleus Has the Clearest AI Visibility Gaps

Questions This Section Answers

• How absent is Health Nucleus compared with competitors like tellmeGen and CRI Genetics?
• Which platforms and buyer-intent clusters show zero Health Nucleus presence?
• Did Health Nucleus disappear suddenly or decline progressively since the July 2026 baseline?

The clearest gap is total absence from the AI recommendation layer. Health Nucleus is not present but under-recommended. It is not visible but displaced. It is simply not there.

Every other tracked brand in the category registered at least some presence in the October 2026 qualified observation set. AncestryDNA appeared in 99.6% of observations. 23andMe appeared in 97.2%. MyHeritage DNA appeared in 79.8%. FamilyTreeDNA appeared in 75.7%. Even the smallest brands, tellmeGen at 2.1% and CRI Genetics at 2.3%, retained a measurable foothold. Health Nucleus appeared in 0.00%.

The gap is not confined to a single platform or cluster. Health Nucleus registered zero presence across ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode. It registered zero presence in the Best DNA Testing Kits - Discovery & Evaluation cluster, the only cluster with sufficient coverage in the current benchmark.

The competitive displacement pattern is stark. When buyers ask AI systems for a recommended DNA testing kit, the recommendation set is populated by AncestryDNA, 23andMe, MyHeritage DNA, FamilyTreeDNA, and a long tail of smaller brands. Health Nucleus is not part of that set. The brand has no recommendation footprint to defend and no shortlist position to recover.

The benchmark also shows the decline was progressive. Health Nucleus fell from 0.8% coverage in July 2026 to 0.00% in October 2026, declining in each of the three months since the baseline. This is not a single-month anomaly. It is a sustained exit from the recommendation layer.

Biggest Opportunity

Questions This Section Answers

• What would re-entry into the AI recommendation set actually require for Health Nucleus?
• Which smaller DNA testing brands prove the category is still open to marginal players?

The single biggest opportunity for Health Nucleus is re-entry into the brand recommendation cluster, where every other tracked competitor still holds at least a marginal position.

The Best DNA Testing Kits - Discovery & Evaluation cluster produced 563 qualified observations in October 2026, all of them representing discovery and consideration intent. Buyers are asking AI systems which DNA testing kit to choose. Health Nucleus is not in the answer.

Re-entry does not require capturing the category lead. It requires establishing a valid recommendation footprint in the prompts where the brand has a legitimate claim to be mentioned. That means building the owned answer layer, the citation architecture, and the public evidence layer that AI systems draw on when forming recommendations. The benchmark shows the category is not closed. Smaller brands such as African Ancestry, CRI Genetics, and tellmeGen retain marginal presence. The path back into the recommendation set is narrow but it exists.

Competitive Landscape

Questions This Section Answers

• Which DNA testing kits hold the strongest AI recommendation power, and where does Health Nucleus land among them?
• How far behind the category leaders is Health Nucleus on top-three and rank-one recommendation rates?

AncestryDNA holds dominant recommendation power in the DNA Testing Kits category, with 23andMe as the strongest challenger and MyHeritage DNA as the third-ranked brand. Health Nucleus sits at the bottom of the tracked set with no recommendation-stage presence at all.

Average recommended rank covers rank-eligible recommendations only.

Health Nucleus is the only tracked brand with a 0.00% top-three rate and no rank-eligible recommendations. The table shows a category with a clear top tier, a contested middle, and a long tail of marginal players. Health Nucleus sits below the long tail.

Prompt Evidence

Questions This Section Answers

• When buyers ask AI systems for the best DNA testing kit, which brands appear instead of Health Nucleus?

ChatGPT / Best DNA Testing Kits - Discovery & Evaluation Prompt: "What is the best DNA ancestry kit to buy?" Result: Health Nucleus was not mentioned. The recommendation set was populated by AncestryDNA, 23andMe, and MyHeritage DNA.

Google AI Overviews / Best DNA Testing Kits - Discovery & Evaluation Prompt: "What is the most accurate DNA test kit?" Result: Health Nucleus was not mentioned. AncestryDNA held the rank-one position, with 23andMe and MyHeritage DNA in the top three.

Perplexity / Best DNA Testing Kits - Discovery & Evaluation Prompt: "Which DNA test is best for Middle Eastern?" Result: Health Nucleus was not mentioned. The response surfaced AncestryDNA and 23andMe as the primary recommendations.

Copilot / Best DNA Testing Kits - Discovery & Evaluation Prompt: "What is the best DNA test for family tree?" Result: Health Nucleus was not mentioned. FamilyTreeDNA and AncestryDNA were the primary recommendations, with MyHeritage DNA appearing in the top three.

What CiteWorks Studio Would Do Next

Phase 1: AI Visibility Market Discovery Audit Map every prompt in the Best DNA Testing Kits cluster where Health Nucleus should have a legitimate claim to appear, and identify the specific question types where the brand is absent.

Phase 2: Recommendation Readiness Plan Define the brand attributes, differentiators, and use cases that AI systems would need to retrieve in order to recommend Health Nucleus alongside the category leaders.

Phase 3: Owned Answer Layer Buildout Build the owned pages, structured content, and direct-answer assets that give AI systems a clear, retrievable source for what Health Nucleus offers and who it is for.

Phase 4: Citation / Authority Layer Development Develop the third-party citations, review coverage, and public evidence sources that AI systems draw on when forming recommendations in the DNA testing category.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track month-over-month whether Health Nucleus re-enters the recommendation set, which platforms surface it first, and which prompts convert from absence to valid recommendation.

Why This Matters

AI presence alone is not enough. But for Health Nucleus, the problem is more fundamental: there is no presence to build on. The brand has exited the AI recommendation layer entirely, and the category continues to move without it.

The next move is not a broad visibility campaign. It is targeted correction of the prompt, page, and citation layers that determine whether AI systems can find, retrieve, and recommend Health Nucleus when buyers ask which DNA testing kit to choose. The benchmark shows the category is not closed. The path back in requires building the evidence layer that AI systems draw on when forming recommendations.

Core Metrics

Sentiment Score

Questions This Section Answers

• Why is Health Nucleus's net sentiment score of 0.0000 not the same as neutral framing?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

For Health Nucleus, the dataset contains zero positive, zero neutral, and zero negative mentions, so no sentiment score can be calculated from observed framing. The reported net sentiment score of 0.0000 is not a signal of neutral framing. It is a signal of no framing at all.

This matters because unclassified mention counts are misleading. A brand with zero mentions is not the same as a brand with neutral mentions. It is absent. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal. Counting all mentions as wins is bad measurement. For Health Nucleus, the measurement problem is simpler: there are no mentions to classify.

Classified sentiment is required before interpreting AI visibility. For Health Nucleus, the first step is establishing any visibility at all.

Sentiment by Platform

Methodology

Questions This Section Answers

• How were the 563 qualified observations selected from the 800 collected prompts?
• Why does Health Nucleus show N/A for average recommended rank?

1. This report is a benchmark-based analysis of Health Nucleus within the DNA Testing Kits category, drawing on the LLM Authority Index AI Visibility Market Discovery Index for October 2026 and the associated CiteWorks Studio AI Visibility Market Discovery case study.
2. The reporting month is October 2026. The benchmark series began with a July 2026 baseline and includes monthly measurements for July, August, September, and October 2026.
3. Six AI platform families were tracked: ChatGPT, Copilot, Gemini, Perplexity, Google AI Overviews, and Google AI Mode.
4. The October 2026 measurement began with 800 prompt-surface observations and produced 563 qualified observations after qualification. The July 2026 baseline produced 594 qualified observations.
5. Ten brands were tracked in the category: AncestryDNA, 23andMe, MyHeritage DNA, FamilyTreeDNA, Living DNA, Nebula Genomics, African Ancestry, CRI Genetics, tellmeGen, and Health Nucleus.
6. All qualified observations in the October 2026 benchmark fell into the Brand Recommendation buyer-intent cluster, representing discovery and consideration intent. The Pricing & Value and Multi-Brand Comparison clusters produced no qualified observations in the current public series.
7. The benchmark uses a two-stage qualification funnel. The raw collection universe of 800 prompt-surface observations is narrowed to 793 relevant observations and then to 563 qualified benchmark observations. Brand-level percentages use the qualified set as the public denominator.
8. A mention is counted when a brand appears in a qualified AI response in any form, including neutral references, comparison anchors, and cautionary mentions.
9. A valid recommendation is counted when a brand receives an explicit recommendation in a qualified AI response. Negative, neutral, cautionary, comparison-anchor, and listed-only mentions are not counted as valid recommendations unless the dataset explicitly marks them as such.
10. Top-three rate measures the share of qualified observations in which a brand appears among the top three recommended options. Rank-one rate measures the share in which the brand is the first-listed recommendation.
11. Average recommended rank covers rank-eligible recommendations only. Health Nucleus has no rank-eligible recommendations, so the metric is reported as N/A.
12. The benchmark does not measure market share, attributable sales, every possible AI response, organic-search ranking, social mention volume, private or sponsored channels, or causality from a metric movement alone. The index records the change; it does not by itself establish why the change occurred.

See How AI Is Recommending Your Brand

The public benchmark shows where Health Nucleus stands in the category. A company-level AI visibility audit shows why the brand has fallen out of the recommendation layer and which prompts, platforms, and citation sources offer the clearest path back in. The audit maps the prompt, surface, competitor, ranking, sentiment, and evidence-source patterns into a prioritized visibility strategy built around the specific gaps identified in this report.